Chemical Properties of Androst-4-en-9«alpha»-fluoro-17«alpha»-methyl-3«alpha»,6«beta»,11«beta»,17«beta»-tetraol, TMS

Androst-4-en-9«alpha»-fluoro-17«alpha»-methyl-3«alpha»,6«beta»,11«beta»,17«beta»-tetraol, TMS

PDF Excel Molecule Calculator
InChI
InChI=1S/C32H63FO4Si4/c1-29-18-16-23(34-38(4,5)6)20-26(29)27(35-39(7,8)9)21-25-24-17-19-31(3,37-41(13,14)15)30(24,2)22-28(32(25,29)33)36-40(10,11)12/h20,23-25,27-28H,16-19,21-22H2,1-15H3
InChI Key
UUYYWGFQQAOGRS-UHFFFAOYSA-N
Formula
C32H63FO4Si4
SMILES
CC1(O[Si](C)(C)C)CCC2C3CC(O[Si](C)(C)C)C4=CC(O[Si](C)(C)C)CCC4(C)C3(F)C(O[Si](C)(C)C)CC21C
Molecular Weight1
643.18
Cheméo is a service of Céondo GmbH, since 2007, we provide simulation, modelling and software development services for the industry. Do not hesitate to contact us for your projects.

Physical Properties

Property Value Unit Source
log10WS -0.65 Crippen Calculated Property
logPoct/wat 9.532 Crippen Calculated Property
Inp [2858.00; 2858.00]   Show Hide
Inp 2858.00 NIST
Inp 2858.00 NIST

Similar Compounds

Dexamethasone, 6-hydroxy, MO TMS. azadirachtin. 6«beta»-Hydroxy-Fluoxymesterone, tetra-TMS (2,4-diene). Pholcodine. Dihydroergokryptine. Crinan-11-ol, 1,2-didehydro-3-methoxy-, (3«beta»,5«alpha»,11R,13«beta»,19«alpha»)-. [2,2'-Bimorphinan]-3,3',6,6'-tetrol, 7,7',8,8'-tetradehydro-4,5:4',5'-diepoxy-17,17'-dimethyl-, (5«alpha»,6«alpha»)-(5'«alpha»,6'«alpha»)-. Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5«alpha»,6«alpha»)-, bis(trifluoroacetate) (ester). Triazolo[4,5-d]pyrimidin-7-ol,3h-v-, 5-amino-3-(2',3'-o-isopropylidene-beta-d-ribofuranosyl)-, 5'-diphenyl phosphate (keto form). Deserpidine. Paclitaxel. Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'«alpha»,10«alpha»)-. Ergotamine. Ergocristine. Codeine-propionyl.

Find more compounds similar to Androst-4-en-9«alpha»-fluoro-17«alpha»-methyl-3«alpha»,6«beta»,11«beta»,17«beta»-tetraol, TMS.

Sources

Note: Cheméo is only indexing the data, follow the source links to retrieve the latest data. The source is also providing more information like the publication year, authors and more. Take the time to validate and double check the source of the data.